HIGHLIGHTS
- who: PI and collaborators from the University Hospital Fundaciou0301n Jimu00e9nez Du0131u00b4az, Spain have published the paper: The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy, in the Journal: (JOURNAL)
SUMMARY
Adoptive T-cell therapy (ACT) is a form of cellular immunotherapy in which tumor-reactive T_cells recognize and eliminate malignant cells after infusion into patients. In the past few decades, cell-based therapies with chimeric antigen receptor (CAR) T_cells, engineered T_cell receptor (eTCR) T_cells, tumor-infiltrating lymphocytes (TILs), and other antigenspecific T_cells have rapidly developed and shown enormous . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.